27737333|t|Risk factors analyses for lateral lymph node metastases in papillary thyroid carcinomas: a retrospective study of 356 patients
27737333|a|The aim of this study was to investigate the incidence and risk factors for lateral lymph node metastasis (LLNM) in patients with papillary thyroid carcinoma (PTC). 356 patients diagnosed with PTC who underwent total thyroidectomy and central lymph node dissection and lateral lymph node dissection between January 2005 and December 2011 were enrolled. The relation between LLNM and clinicopathological features such as gender, age, tumor size, tumor spread, psammoma bodies, tumor multifocality, extrathyroidal extension (ETE), unilateral or bilateral disease, tumor primary location and central lymph node metastases (CLNM) was analyzed. The rate of LLNM was 75.0%. In the univariate analysis, it was significantly associated with age, tumor size, tumor spread, extrathyroidal extension, primary tumor location and central lymph node metastasis (p < 0.05). In contrast, in the multivariate analysis, it was significantly associated with primary tumor location, central lymph node metastasis (p < 0.05) and tumor size > 1.5 cm with p = 0.05 but was unrelated to the other factors. Patients with PTC, with the primary tumor located in the upper part of the lobe and positive central compartment lymph node metastasis with a tumor size > 1.5 cm diameter are more likely to have LLNM. Therefore, more meticulous evaluations including the lateral lymph nodes should be performed before surgery.
27737333	0	12	Risk factors	T033	C0035648
27737333	13	21	analyses	T062	C0936012
27737333	26	55	lateral lymph node metastases	T191	C0686619
27737333	59	87	papillary thyroid carcinomas	T191	C0238463
27737333	91	110	retrospective study	T062	C0035363
27737333	118	126	patients	T101	C0030705
27737333	143	148	study	T062	C0035363
27737333	156	167	investigate	T169	C1292732
27737333	172	181	incidence	T081	C0021149
27737333	186	198	risk factors	T033	C0035648
27737333	203	232	lateral lymph node metastasis	T191	C0686619
27737333	234	238	LLNM	T191	C0686619
27737333	243	251	patients	T101	C0030705
27737333	257	284	papillary thyroid carcinoma	T191	C0238463
27737333	286	289	PTC	T191	C0238463
27737333	296	304	patients	T101	C0030705
27737333	305	314	diagnosed	T033	C0011900
27737333	320	323	PTC	T191	C0238463
27737333	338	357	total thyroidectomy	T061	C0193788
27737333	362	391	central lymph node dissection	T061	C3899695
27737333	396	403	lateral	T082	C0205093
27737333	404	425	lymph node dissection	T061	C0242382
27737333	501	505	LLNM	T191	C0686619
27737333	510	529	clinicopathological	T169	C1521733
27737333	530	538	features	T080	C2348519
27737333	547	553	gender	T032	C0079399
27737333	555	558	age	T032	C0001779
27737333	560	570	tumor size	T082	C0475440
27737333	572	584	tumor spread	T033	C1334939
27737333	586	601	psammoma bodies	T031	C0391863
27737333	603	622	tumor multifocality	T033	C1302461
27737333	624	648	extrathyroidal extension	T191	C3899369
27737333	650	653	ETE	T191	C3899369
27737333	656	666	unilateral	T033	C4035394
27737333	670	687	bilateral disease	T033	C1511113
27737333	689	694	tumor	T191	C0027651
27737333	695	702	primary	T080	C0205225
27737333	703	711	location	T082	C0450429
27737333	716	745	central lymph node metastases	T191	C0686619
27737333	747	751	CLNM	T191	C0686619
27737333	757	765	analyzed	T062	C0936012
27737333	771	775	rate	T081	C1521828
27737333	779	783	LLNM	T191	C0686619
27737333	802	821	univariate analysis	T062	C0683962
27737333	844	859	associated with	T080	C0332281
27737333	860	863	age	T032	C0001779
27737333	865	875	tumor size	T082	C0475440
27737333	877	889	tumor spread	T033	C1334939
27737333	891	915	extrathyroidal extension	T191	C3899369
27737333	917	924	primary	T080	C0205225
27737333	925	930	tumor	T191	C0027651
27737333	931	939	location	T082	C0450429
27737333	944	973	central lymph node metastasis	T191	C0686619
27737333	1006	1027	multivariate analysis	T081	C0026777
27737333	1050	1065	associated with	T080	C0332281
27737333	1066	1073	primary	T080	C0205225
27737333	1074	1079	tumor	T191	C0027651
27737333	1080	1088	location	T082	C0450429
27737333	1090	1119	central lymph node metastasis	T191	C0686619
27737333	1135	1145	tumor size	T082	C0475440
27737333	1200	1207	factors	T169	C1521761
27737333	1209	1217	Patients	T101	C0030705
27737333	1223	1226	PTC	T191	C0238463
27737333	1237	1244	primary	T080	C0205225
27737333	1245	1250	tumor	T191	C0027651
27737333	1251	1258	located	T082	C0450429
27737333	1266	1276	upper part	T082	C1254362
27737333	1284	1288	lobe	T023	C0796494
27737333	1293	1301	positive	T033	C1446409
27737333	1302	1321	central compartment	UnknownType	C0682583
27737333	1322	1343	lymph node metastasis	T191	C0686619
27737333	1351	1361	tumor size	T082	C0475440
27737333	1371	1379	diameter	T081	C1301886
27737333	1404	1408	LLNM	T191	C0686619
27737333	1426	1448	meticulous evaluations	T058	C0220825
27737333	1463	1470	lateral	T082	C0205093
27737333	1471	1482	lymph nodes	T023	C0024204
27737333	1510	1517	surgery	T061	C0543467